Cubist Systematic Strategies’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,144
| Closed | -$19K | – | 5040 |
|
|
2022
Q2 | $19K | Buy |
13,144
+5,944
| +83% | +$4.37K | ﹤0.01% | 4228 |
|
|
2022
Q1 | $8K | Sell |
7,200
-182,787
| -96% | -$298K | ﹤0.01% | 3503 |
|
|
2021
Q4 | $475K | Buy |
189,987
+170,156
| +858% | +$669K | ﹤0.01% | 2486 |
|
|
2021
Q3 | $102K | Sell |
19,831
-16,866
| -46% | -$102K | ﹤0.01% | 2739 |
|
|
2021
Q2 | $305K | Sell |
36,697
-6,126
| -14% | -$51.6K | ﹤0.01% | 2319 |
|
|
2021
Q1 | $373K | Buy |
42,823
+26,956
| +170% | +$279K | ﹤0.01% | 2129 |
|
|
2020
Q4 | $172K | Buy |
15,867
+7,661
| +93% | +$94.5K | ﹤0.01% | 2294 |
|
|
2020
Q3 | $98K | Sell |
8,206
-4,339
| -35% | -$58.1K | ﹤0.01% | 2288 |
|
|
2020
Q2 | $201K | Sell |
12,545
-23,107
| -65% | -$403K | ﹤0.01% | 2031 |
|
|
2020
Q1 | $553K | Buy |
35,652
+1,623
| +5% | +$34.9K | 0.01% | 1192 |
|
|
2019
Q4 | $837K | Sell |
34,029
-5,763
| -14% | -$85.5K | 0.02% | 1266 |
|
|
2019
Q3 | $410K | Buy |
39,792
+21,138
| +113% | +$267K | 0.01% | 1402 |
|
|
2019
Q2 | $234K | Sell |
18,654
-2,126
| -10% | -$27.4K | ﹤0.01% | 1971 |
|
|
2019
Q1 | $257K | Sell |
20,780
-59,343
| -74% | -$663K | 0.01% | 1610 |
|
|
2018
Q4 | $494K | Buy |
80,123
+70,406
| +725% | +$538K | 0.02% | 976 |
|
|
2018
Q3 | $103K | Sell |
9,717
-14,319
| -60% | -$163K | 0.01% | 1601 |
|
|
2018
Q2 | $326K | Sell |
24,036
-1,495
| -6% | -$23.3K | 0.02% | 1037 |
|
|
2018
Q1 | $453K | Buy |
25,531
+11,693
| +84% | +$197K | 0.03% | 863 |
|
|
2017
Q4 | $174K | Buy |
+13,838
| New | +$201K | 0.01% | 1574 |
|
|
2015
Q3 | – | Sell |
-1,031
| Closed | -$25K | – | 2072 |
|
|
2015
Q2 | $25K | Sell |
1,031
-3,875
| -79% | -$74.6K | ﹤0.01% | 1748 |
|
|
2015
Q1 | $92K | Buy |
+4,906
| New | +$101K | ﹤0.01% | 1681 |
|
|
2014
Q4 | – | Sell |
-1,560
| Closed | -$42K | – | 2097 |
|
|
2014
Q3 | $42K | Buy |
+1,560
| New | +$48.5K | ﹤0.01% | 1649 |
|
Other funds holding EPZM
Cubist Systematic Strategies's EPZM Position: Q3 2022 in Review
Cubist Systematic Strategies sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 13,144 shares — an estimated $19K sold.
Cubist Systematic Strategies first reported a position in EPZM in Q3 2014 and held it in 22 quarters. The position peaked at $837K in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Cubist Systematic Strategies reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Cubist Systematic Strategies sold 13,144 Epizyme, Inc shares in Q3 2022, an estimated $19K.
- Cubist Systematic Strategies first reported a position in Epizyme, Inc in Q3 2014 and held it in 22 quarters.
- Cubist Systematic Strategies's Epizyme, Inc position peaked at $837K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.